Yahoo Web Search

  1. Ad
    related to Novartis AG
  1. Is Novartis AG (NVS) A Good Stock To Buy According To Hedge Funds?

    Insider Monkey via Yahoo FinanceOct 07 15:14 PM

    With this in mind, let’s take a look at the recent hedge fund activity surrounding Novartis AG (NYSE:NVS). Novartis AG (NYSE:NVS) investors should pay attention to ...

  2. Is Novartis AG (VTX:NOVN) Trading At A 38% Discount?

    Simply Wall St. via Yahoo FinanceOct 10 4:25 AM

    Does the October share price for Novartis AG (VTX:NOVN) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows ...

  3. Novartis AG NVS announced additional positive data from the ongoing PREVENT study on spondylitis drug, Cosentyx (secukinumab). PREVENT is an ongoing two-year randomized, double-blind ...

  4. Novartis (NVS) Announces Data on Asthma Drugs & Kisqali

    Zacks via Yahoo FinanceOct 02 13:53 PM

    Novartis AG NVS announced mixed results from the phase III IRIDIUM study on investigational, once-daily, inhaled QVM149 (indacaterol acetate, glycopyrronium bromide and mometasone ...

  5. Novartis' (NVS) Wet AMD Drug Beovu Obtains FDA Approval

    Zacks via Yahoo FinanceOct 09 15:10 PM

    Swiss pharma giant Novartis AG NVS announced that the FDA approved its ophthalmology drug Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration ...

  6. The recent FDA approval of Novartis AG’s NVS Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD) has put the spotlight on this promising ...

  7. Roche Holding AG RHHBY announced that the FDA approved the label expansion of Rituxan (rituximab). The agency approved the drug, in combination with glucocorticoids, for the treatment ...

  8. A few FDA approvals came through, with Puma Biotechnology Inc (NASDAQ: PBYI) getting a label expansion for its breast cancer drug Nerlynx and Novartis AG (NYSE: NVS)'s Entresto ...

  9. Investors focused on the Medical space have likely heard of Novartis (NVS), but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's ...

  10. This week, the FDA approved Novartis' NVS potential blockbuster eye drug, Beovu. J&J JNJ submitted a regulatory application seeking label expansion approval of its plaque psoriasis drug ...

  1. Ads
    related to Novartis AG